STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Accenture Nominates Dr. Martin Brudermüller, Chief Executive Officer and Chairman of the Board of Executive Directors of BASF SE, to Join its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Accenture (ACN) nominates Dr. Martin Brudermüller, CEO of BASF SE, for election to the Board of Directors, bringing expertise in chemicals, finance, and sustainability. If elected at the annual general meeting on January 31, 2024, he will join the Board and serve on the Audit Committee.
Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Accenture (NYSE: ACN) announced that its Board of Directors has nominated Dr. Martin Brudermüller for election to the Board at Accenture’s annual general meeting of shareholders on January 31, 2024. Dr. Brudermüller, 62, is Chief Executive Officer and Chairman of the Board of Executive Directors of BASF SE (ETR: BAS). He will be listed as a director nominee in Accenture’s 2023 proxy statement, which is scheduled to be filed with the Securities and Exchange Commission next week.

“Martin is a dynamic global business leader who will bring to our board his deep expertise in chemicals, finance, capital markets and sustainability, along with his significant experience in transformation,” said Julie Sweet, chair and CEO, Accenture. “His wide-ranging perspective will be enormously valuable as we help companies embrace a strategy of total enterprise reinvention and create 360° value for all our stakeholders.”

If elected by shareholders at the annual general meeting, Dr. Brudermüller will join Accenture’s Board of Directors immediately afterward and will serve on the Audit Committee. Together with our other nominees, the Board would comprise 11 directors, 10 of whom will be external and independent. Ms. Sweet is the Board’s only internal director.

Dr. Brudermüller has been Chief Executive Officer and Chairman of the Board of Executive Directors of BASF SE since 2018. He joined BASF in 1988, and during his career has held a variety of leadership roles, including Vice Chairman of the Board of Executive Directors and Chief Technology Officer, as well as a Member of the Board of Executive Directors for ten years for the Asia Pacific region, located in Hong Kong. Dr. Brudermüller is a member of the supervisory board of Mercedes-Benz Group AG.

Dr. Brudermüller holds a master’s degree in chemistry from the University of Karlsruhe, Germany. After earning a doctorate there in 1987, he completed a post-doctorate at the University of California, Berkeley.

About Accenture

Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale. We are a talent and innovation led company with 733,000 people serving clients in more than 120 countries. Technology is at the core of change today, and we are one of the world’s leaders in helping drive that change, with strong ecosystem relationships. We combine our strength in technology with unmatched industry experience, functional expertise and global delivery capability. We are uniquely able to deliver tangible outcomes because of our broad range of services, solutions and assets across Strategy & Consulting, Technology, Operations, Industry X and Accenture Song. These capabilities, together with our culture of shared success and commitment to creating 360° value, enable us to help our clients succeed and build trusted, lasting relationships. We measure our success by the 360° value we create for our clients, each other, our shareholders, partners and communities. Visit us at www.accenture.com.

Rachel Frey

Accenture

+1 917 452 4421

rachel.frey@accenture.com

Source: Accenture

FAQ

Who has Accenture (ACN) nominated for election to its Board of Directors?

Accenture has nominated Dr. Martin Brudermüller, CEO of BASF SE, for election to the Board of Directors.

When is Accenture's annual general meeting scheduled?

Accenture's annual general meeting is scheduled for January 31, 2024.

What expertise does Dr. Martin Brudermüller bring to Accenture's Board?

Dr. Martin Brudermüller brings expertise in chemicals, finance, capital markets, and sustainability to Accenture's Board.

What role will Dr. Martin Brudermüller serve on Accenture's Board if elected?

If elected, Dr. Martin Brudermüller will join Accenture's Board of Directors and serve on the Audit Committee.

What is Dr. Martin Brudermüller's current position at BASF SE?

Dr. Martin Brudermüller is the Chief Executive Officer and Chairman of the Board of Executive Directors of BASF SE.

Accenture PLC

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Stock Data

228.12B
624.69M
0.07%
73.08%
0.92%
Information Technology Services
Services-business Services, Nec
Link
United States of America
DUBLIN